Who can take part?
Are 22 years or older;
Have been diagnosed with moderate to severe OSA; and
Have refused, or cannot tolerate, CPAP therapy.
About aura6000® HGNS Therapy
See if you may qualify
What happens during the study?
The OSPREY study is accepting volunteers in the US with moderate to severe sleep apnea. The study involves up to 17 visits over a 16-month period. The study is broken into 4 parts:
- Screening: Participants visit the research center to review health history and answer questions. During this time, a few sleep studies are done to make sure HGNS therapy is the right option.
- Implant: During a same-day outpatient procedure, the aura6000® HGNS device is implanted beneath the skin.
- Group Assignment: Participants are randomly assigned into one of two groups. Group 1 will have the device turned on 1-month after implant, whereas Group 2 will have the device turned on 7 months after implant.
- Follow Up: Participants visit the research center and sleep lab regularly for overnight sleep tests. These visits allow the study team to program the device and see if the implant is helping. There are also questionnaires that participants fill out to measure sleep quality.
If you are eligible for the study, the study team will contact you to give you more information so you can make an informed decision about participating. The study team will be available at every step along the way to support you and answer your questions.
If you qualify, and decide to participate, all study-related care will be given at no cost to you.